Evo Fund short positions

As of 2026-11-16, Evo Fund reports short positions of 0.5% or more in 1 stocks. It ranks #48 of 68 institutions by number of stocks shorted. Its largest position is Jibannet Holdings Co.,Ltd. (5.27%). Its first report on record is from 2018-01-09, with 211 reports across 16 stocks so far.

Stocks held (0.5% or more)
1 stocks
16 stocks reported
Total position (shares)
1,219,800
Total of current positions
Average position
5.27%
Average of current positions
Last report
2026-11-16
Latest calculation date
First reported
2018-01-09
First report on record
Total reports
211
Stocks reported: 16

Holdings count stocks with a position of 0.5% or more reported within the past year. How estimates are calculated

Number of Stocks Held Last 5 years, weekly, positions of 0.5% or more

Number of stocks in which this institution reports a short position of 0.5% or more. Hover over (or tap) the chart to see the weekly count and total shares. The peak was 2 stocks on 2019-09-10.

Last 30 Days Latest reports since 2026-10-18

New positions 1

Increased 0

No increases

Decreased (covering) 0

No decreases

Fell below 0.5% / closed 0

No closed positions

Breakdown by Sector Current positions, TSE 33 sectors

Stocks in which Evo Fund holds a short position of 0.5% or more, grouped by sector. The most common sector is Services (1 stocks).

SectorStocksShareTotal %
Services 1 100.00% 5.27%

By market segment

Current Positions Latest report for each stock

Last report Stock Position (shares) Ratio Change Status
2026-11-16 ERTH Group Co.,Ltd.6072 Position 1,219,800 shares Ratio 5.27% ▲1.29% +299,000 Holding
2018-12-12 LEGAL CORPORATION3497 Position 11,800 shares Ratio 0.41% ▼0.17% −5,000 Below 0.5%
2018-02-07 ARDEPRO Co.,Ltd.8925 Position 1,120,500 shares Ratio 0.40% ▼0.11% −300,000 Below 0.5%
2020-01-15 FRUTA FRUTA INC.2586 Position 0 shares Ratio 0.00% ▼17.70% −339,800 Closed
2025-06-24 Metaplanet Inc.3350 Position 0 shares Ratio 0.00% ▼4.99% −30,000,000 Closed
2020-12-25 FUJITA CORPORATION Co.,Ltd.3370 Position 0 shares Ratio 0.00% ▼0.91% −17,500 Closed
2025-12-26 AltPlusInc.3672 Position 0 shares Ratio 0.00% ▼0.69% −467,100 Closed
2025-06-05 Remixpoint,inc.3825 Position 0 shares Ratio 0.00% ▼1.47% −1,844,500 Closed
2024-04-19 SymBio Pharmaceuticals Limited4582 Position 0 shares Ratio 0.00% ▼1.73% −775,100 Closed
2025-08-12 RIBOMIC Inc.4591 Position 0 shares Ratio 0.00% ▼4.48% −2,000,500 Closed
2025-09-11 Def consulting,inc.4833 Position 0 shares Ratio 0.00% ▼8.02% −2,889,000 Closed
2026-02-09 W-SCOPE Corporation6619 Position 0 shares Ratio 0.00% ▼2.24% −1,290,000 Closed
2020-01-30 PIXELA CORPORATION6731 Position 0 shares Ratio 0.00% ▼1.44% −1,000,000 Closed
2021-04-09 The Lead Co.,Inc.6982 Position 0 shares Ratio 0.00% ▼0.65% −17,000 Closed
2025-08-25 MAC HOUSE CO.,LTD.7603 Position 0 shares Ratio 0.00% ▼9.91% −2,240,000 Closed
2020-05-15 Kozosushi Co.,LTD.9973 Position 0 shares Ratio 0.00% ▼1.65% −1,693,100 Closed

Longest-Held Positions Current positions, oldest first report first

StockFirst reportedDaysCurrent %
Jibannet Holdings Co.,Ltd.6072 2026-11-04 13 days 5.27%

The first-reported date is when this institution first disclosed a position in the stock. The period may include times when the position fell below 0.5%.

Institutions Shorting the Same Stocks By number of overlapping stocks

Institutions reporting short positions of 0.5% or more in the same stocks that Evo Fund currently holds (1 stocks).

Reports by Year By calculation year

YearReportsStocks reported
2026 7 2
2025 26 6
2024 33 2
2023 23 1
2021 3 1
2020 22 4
2019 82 3
2018 15 2

Disclosure History Latest 100

Trade date Stock Position (shares) Ratio Change Short seller
2026-11-16 ERTH Group Co.,Ltd.6072 Position 1,219,800 shares Ratio 5.27% ▲1.29% +299,000 Evo Fund
2026-11-04 ERTH Group Co.,Ltd.6072 Position 920,800 shares Ratio 3.98% ▲3.98% Evo Fund
2026-02-09 W-SCOPE Corporation6619 Position 0 shares Ratio 0.00% ▼2.24% −1,290,000 Evo Fund
2026-02-06 W-SCOPE Corporation6619 Position 1,290,000 shares Ratio 2.24% ▲0.40% +230,000 Evo Fund
2026-02-05 W-SCOPE Corporation6619 Position 1,060,000 shares Ratio 1.84% ▲0.70% +405,000 Evo Fund
2026-02-04 W-SCOPE Corporation6619 Position 655,000 shares Ratio 1.14% ▲0.47% +268,900 Evo Fund
2026-02-03 W-SCOPE Corporation6619 Position 386,100 shares Ratio 0.67% ▲0.67% Evo Fund
2025-12-26 AltPlusInc.3672 Position 0 shares Ratio 0.00% ▼0.69% −467,100 Evo Fund
2025-11-27 AltPlusInc.3672 Position 467,100 shares Ratio 0.69% ▲0.69% Evo Fund
2025-09-11 Def consulting,inc.4833 Position 0 shares Ratio 0.00% ▼8.02% −2,889,000 Evo Fund
2025-09-04 Def consulting,inc.4833 Position 2,889,000 shares Ratio 8.02% ▲0.69% +254,000 Evo Fund
2025-09-03 Def consulting,inc.4833 Position 2,635,000 shares Ratio 7.33% ▲0.58% +225,000 Evo Fund
2025-09-02 Def consulting,inc.4833 Position 2,410,000 shares Ratio 6.75% ▲0.55% +195,000 Evo Fund
2025-09-01 Def consulting,inc.4833 Position 2,215,000 shares Ratio 6.20% ▲1.52% +545,000 Evo Fund
2025-08-29 Def consulting,inc.4833 Position 1,670,000 shares Ratio 4.68% ▲1.11% +395,900 Evo Fund
2025-08-28 Def consulting,inc.4833 Position 1,274,100 shares Ratio 3.57% ▲3.15% Evo Fund
2025-08-25 MAC HOUSE CO.,LTD.7603 Position 0 shares Ratio 0.00% ▼9.91% −2,240,000 Evo Fund
2025-08-22 MAC HOUSE CO.,LTD.7603 Position 2,240,000 shares Ratio 9.91% ▲1.21% +274,400 Evo Fund
2025-08-21 MAC HOUSE CO.,LTD.7603 Position 1,965,600 shares Ratio 8.70% ▲1.31% +295,600 Evo Fund
2025-08-20 MAC HOUSE CO.,LTD.7603 Position 1,670,000 shares Ratio 7.39% ▲5.04% +1,138,200 Evo Fund
2025-08-19 MAC HOUSE CO.,LTD.7603 Position 531,800 shares Ratio 2.35% ▲1.79% +405,800 Evo Fund
2025-08-18 MAC HOUSE CO.,LTD.7603 Position 126,000 shares Ratio 0.56% ▲0.56% Evo Fund
2025-08-12 RIBOMIC Inc.4591 Position 0 shares Ratio 0.00% ▼4.48% −2,000,500 Evo Fund
2025-08-08 RIBOMIC Inc.4591 Position 2,000,500 shares Ratio 4.48% ▲3.43% +1,532,500 Evo Fund
2025-08-07 RIBOMIC Inc.4591 Position 468,000 shares Ratio 1.05% ▲1.05% Evo Fund
2025-06-24 Metaplanet Inc.3350 Position 0 shares Ratio 0.00% ▼4.99% −30,000,000 Evo Fund
2025-06-17 Metaplanet Inc.3350 Position 30,000,000 shares Ratio 4.99% ▲0.65% +3,957,500 Evo Fund
2025-06-11 Metaplanet Inc.3350 Position 26,042,500 shares Ratio 4.34% ▲0.59% +3,529,800 Evo Fund
2025-06-10 Metaplanet Inc.3350 Position 22,512,700 shares Ratio 3.75% ▲1.53% +9,178,100 Evo Fund
2025-06-09 Metaplanet Inc.3350 Position 13,334,600 shares Ratio 2.22% ▲2.22% Evo Fund
2025-06-05 Remixpoint,inc.3825 Position 0 shares Ratio 0.00% ▼1.47% −1,844,500 Evo Fund
2025-06-04 Remixpoint,inc.3825 Position 1,844,500 shares Ratio 1.47% ▲0.66% +833,900 Evo Fund
2025-05-27 Remixpoint,inc.3825 Position 1,010,600 shares Ratio 0.81% ▲0.32% Evo Fund
2024-12-17 Metaplanet Inc.3350 Position 0 shares Ratio 0.00% ▼4.02% −1,456,200 Evo Fund
2024-12-13 Metaplanet Inc.3350 Position 1,456,200 shares Ratio 4.02% ▲1.62% +584,703 Evo Fund
2024-12-12 Metaplanet Inc.3350 Position 871,497 shares Ratio 2.40% ▲2.40% Evo Fund
2024-04-19 SymBio Pharmaceuticals Limited4582 Position 0 shares Ratio 0.00% ▼1.73% −775,100 Evo Fund
2024-04-10 SymBio Pharmaceuticals Limited4582 Position 775,100 shares Ratio 1.73% ▲0.11% +49,900 Evo Fund
2024-04-01 SymBio Pharmaceuticals Limited4582 Position 725,200 shares Ratio 1.62% ▲0.14% +61,100 Evo Fund
2024-03-29 SymBio Pharmaceuticals Limited4582 Position 664,100 shares Ratio 1.48% ▲0.22% +101,100 Evo Fund
2024-03-28 SymBio Pharmaceuticals Limited4582 Position 563,000 shares Ratio 1.26% ▲0.18% +80,600 Evo Fund
2024-03-27 SymBio Pharmaceuticals Limited4582 Position 482,400 shares Ratio 1.08% ▲0.19% +82,800 Evo Fund
2024-03-26 SymBio Pharmaceuticals Limited4582 Position 399,600 shares Ratio 0.89% ▲0.13% +59,500 Evo Fund
2024-03-25 SymBio Pharmaceuticals Limited4582 Position 340,100 shares Ratio 0.76% ▲0.25% +113,000 Evo Fund
2024-03-21 SymBio Pharmaceuticals Limited4582 Position 227,100 shares Ratio 0.51% ▲0.51% Evo Fund
2024-02-29 SymBio Pharmaceuticals Limited4582 Position 0 shares Ratio 0.00% ▼3.05% Evo Fund
2024-02-26 SymBio Pharmaceuticals Limited4582 Position 962,900 shares Ratio 2.21% ▲0.38% +166,600 Evo Fund
2024-02-22 SymBio Pharmaceuticals Limited4582 Position 796,300 shares Ratio 1.83% ▲0.09% +40,800 Evo Fund
2024-02-21 SymBio Pharmaceuticals Limited4582 Position 755,500 shares Ratio 1.74% ▲0.36% +156,500 Evo Fund
2024-02-20 SymBio Pharmaceuticals Limited4582 Position 599,000 shares Ratio 1.38% ▲0.33% +140,700 Evo Fund
2024-02-19 SymBio Pharmaceuticals Limited4582 Position 458,300 shares Ratio 1.05% ▲0.22% +98,300 Evo Fund
2024-02-16 SymBio Pharmaceuticals Limited4582 Position 360,000 shares Ratio 0.83% ▲0.30% +130,000 Evo Fund
2024-02-15 SymBio Pharmaceuticals Limited4582 Position 230,000 shares Ratio 0.53% ▲0.28% Evo Fund
2024-02-07 SymBio Pharmaceuticals Limited4582 Position 0 shares Ratio 0.00% ▼2.83% −1,197,000 Evo Fund
2024-02-01 SymBio Pharmaceuticals Limited4582 Position 1,197,000 shares Ratio 2.83% ▲0.12% +53,000 Evo Fund
2024-01-26 SymBio Pharmaceuticals Limited4582 Position 1,144,000 shares Ratio 2.71% ▲0.08% +34,000 Evo Fund
2024-01-25 SymBio Pharmaceuticals Limited4582 Position 1,110,000 shares Ratio 2.63% ▲0.04% +13,000 Evo Fund
2024-01-24 SymBio Pharmaceuticals Limited4582 Position 1,097,000 shares Ratio 2.59% ▲0.16% +71,100 Evo Fund
2024-01-19 SymBio Pharmaceuticals Limited4582 Position 1,025,900 shares Ratio 2.43% ▲0.06% +23,800 Evo Fund
2024-01-18 SymBio Pharmaceuticals Limited4582 Position 1,002,100 shares Ratio 2.37% ▲0.25% +105,600 Evo Fund
2024-01-17 SymBio Pharmaceuticals Limited4582 Position 896,500 shares Ratio 2.12% ▲0.21% +89,800 Evo Fund
2024-01-16 SymBio Pharmaceuticals Limited4582 Position 806,700 shares Ratio 1.91% ▲0.26% +108,000 Evo Fund
2024-01-15 SymBio Pharmaceuticals Limited4582 Position 698,700 shares Ratio 1.65% ▲0.31% +132,900 Evo Fund
2024-01-12 SymBio Pharmaceuticals Limited4582 Position 565,800 shares Ratio 1.34% ▲0.33% +138,500 Evo Fund
2024-01-11 SymBio Pharmaceuticals Limited4582 Position 427,300 shares Ratio 1.01% ▲0.14% +59,100 Evo Fund
2024-01-10 SymBio Pharmaceuticals Limited4582 Position 368,200 shares Ratio 0.87% ▲0.87% Evo Fund
2023-12-22 SymBio Pharmaceuticals Limited4582 Position 0 shares Ratio 0.00% ▼2.92% −1,200,000 Evo Fund
2023-12-11 SymBio Pharmaceuticals Limited4582 Position 1,200,000 shares Ratio 2.92% ▲0.26% +107,300 Evo Fund
2023-12-01 SymBio Pharmaceuticals Limited4582 Position 1,092,700 shares Ratio 2.66% ▲0.22% +88,600 Evo Fund
2023-11-30 SymBio Pharmaceuticals Limited4582 Position 1,004,100 shares Ratio 2.44% ▲0.25% +105,000 Evo Fund
2023-11-29 SymBio Pharmaceuticals Limited4582 Position 899,100 shares Ratio 2.19% ▲0.17% +67,500 Evo Fund
2023-11-28 SymBio Pharmaceuticals Limited4582 Position 831,600 shares Ratio 2.02% ▲0.35% +144,100 Evo Fund
2023-11-27 SymBio Pharmaceuticals Limited4582 Position 687,500 shares Ratio 1.67% ▲0.32% +134,400 Evo Fund
2023-11-24 SymBio Pharmaceuticals Limited4582 Position 553,100 shares Ratio 1.35% ▲0.23% +93,200 Evo Fund
2023-11-22 SymBio Pharmaceuticals Limited4582 Position 459,900 shares Ratio 1.12% ▲0.25% +102,900 Evo Fund
2023-11-21 SymBio Pharmaceuticals Limited4582 Position 357,000 shares Ratio 0.87% ▲0.29% +119,200 Evo Fund
2023-11-20 SymBio Pharmaceuticals Limited4582 Position 237,800 shares Ratio 0.58% ▲0.31% Evo Fund
2023-11-10 SymBio Pharmaceuticals Limited4582 Position 0 shares Ratio 0.00% ▼3.01% −1,200,000 Evo Fund
2023-11-07 SymBio Pharmaceuticals Limited4582 Position 1,200,000 shares Ratio 3.01% ▲0.02% +10,000 Evo Fund
2023-11-06 SymBio Pharmaceuticals Limited4582 Position 1,190,000 shares Ratio 2.99% ▲0.17% +65,200 Evo Fund
2023-10-24 SymBio Pharmaceuticals Limited4582 Position 1,124,800 shares Ratio 2.82% ▲0.35% +141,000 Evo Fund
2023-10-23 SymBio Pharmaceuticals Limited4582 Position 983,800 shares Ratio 2.47% ▲0.26% +102,900 Evo Fund
2023-10-20 SymBio Pharmaceuticals Limited4582 Position 880,900 shares Ratio 2.21% ▲0.19% +75,700 Evo Fund
2023-10-19 SymBio Pharmaceuticals Limited4582 Position 805,200 shares Ratio 2.02% ▲0.28% +111,200 Evo Fund
2023-10-18 SymBio Pharmaceuticals Limited4582 Position 694,000 shares Ratio 1.74% ▲0.25% +100,800 Evo Fund
2023-10-17 SymBio Pharmaceuticals Limited4582 Position 593,200 shares Ratio 1.49% ▲0.32% +128,400 Evo Fund
2023-10-16 SymBio Pharmaceuticals Limited4582 Position 464,800 shares Ratio 1.17% ▲0.28% +109,300 Evo Fund
2023-10-13 SymBio Pharmaceuticals Limited4582 Position 355,500 shares Ratio 0.89% ▲0.27% +110,100 Evo Fund
2023-10-12 SymBio Pharmaceuticals Limited4582 Position 245,400 shares Ratio 0.62% ▲0.33% Evo Fund
2021-04-09 The Lead Co.,Inc.6982 Position 0 shares Ratio 0.00% ▼0.65% −17,000 Evo Fund
2021-04-08 The Lead Co.,Inc.6982 Position 17,000 shares Ratio 0.65% ▼0.11% −3,000 Evo Fund
2021-04-07 The Lead Co.,Inc.6982 Position 20,000 shares Ratio 0.76% ▲0.76% Evo Fund
2020-12-25 FUJITA CORPORATION Co.,Ltd.3370 Position 0 shares Ratio 0.00% ▼0.91% −17,500 Evo Fund
2020-12-24 FUJITA CORPORATION Co.,Ltd.3370 Position 17,500 shares Ratio 0.91% ▲0.91% Evo Fund
2020-05-15 Kozosushi Co.,LTD.9973 Position 0 shares Ratio 0.00% ▼1.65% −1,693,100 Evo Fund
2020-05-14 Kozosushi Co.,LTD.9973 Position 1,693,100 shares Ratio 1.65% ▲1.00% +1,023,200 Evo Fund
2020-05-13 Kozosushi Co.,LTD.9973 Position 669,900 shares Ratio 0.65% ▲0.19% Evo Fund
2020-01-30 PIXELA CORPORATION6731 Position 0 shares Ratio 0.00% ▼1.44% −1,000,000 Evo Fund
2020-01-24 PIXELA CORPORATION6731 Position 1,000,000 shares Ratio 1.44% ▲0.09% +66,900 Evo Fund
2020-01-23 PIXELA CORPORATION6731 Position 933,100 shares Ratio 1.35% ▲0.15% +104,300 Evo Fund

FAQ

How many stocks is Evo Fund shorting now?
As of 2026-11-16, it reports short positions of 0.5% or more in 1 stocks, 1,219,800 shares in total.
Which stock has the largest short position by Evo Fund?
Jibannet Holdings Co.,Ltd., at 5.27% of shares outstanding (as of 2026-11-16).
Which stocks has Evo Fund recently started shorting?
In the last 30 days, it newly reported positions of 0.5% or more in 1 stocks, including Jibannet Holdings Co.,Ltd..
Where does this data come from?
It comes from the short position disclosures published by Japan Exchange Group (JPX). Anyone holding a short position of 0.5% or more of shares outstanding must report it, and KabuNote imports these reports daily. Once a position falls below 0.5%, reporting is no longer required, so later balances are not published.

Other Major Short Sellers By number of stocks shorted

See all short sellers